Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

In vitro assay to determine SUMOylation sites on protein substrates

Abstract

Protein SUMOylation regulates the activity of a wide range of cellular substrates, and the identification of small ubiquitin-related modifier (SUMO)-modified sites is often required to understand how this modification affects protein function. However, the site-specific identification of modified lysine residues by mass spectrometry (MS) remains challenging because of the dynamic nature of this modification, its low stoichiometry and the relatively large SUMO remnant left on peptide backbones after tryptic digestion. Here we report a versatile method to identify sites and to profile the extent of modification on recombinant proteins from in vitro SUMOylation assays. We define the steps required for sample preparation, and we describe how to perform proper controls and conduct the liquid chromatography-MS (LC-MS) and bioinformatics analyses. Native protein substrates can be used for the assay, although we recommend the use of His-tagged proteins to facilitate removal of contaminants. The procedure was developed for human SUMO paralogs, and it requires <2 d for completion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Protein SUMOylation cascade.
Figure 2: Experimental design for the SUMO site identification of target proteins using an in vitro SUMOylation assay.
Figure 3: Extracted ion chromatograms of SUMOylated peptides.
Figure 4: Kinetic profile of in vitro SUMOylation of RanGAP Lys-524 SUMOylation.
Figure 5: MS/MS spectrum of the [M+3H]3+ ion at m/z 701.0100 from the in vitro SUMOylation of HSP27 at Lys198.
Figure 6: Overlap of the SUMO sites identified from in vitro and in vivo experiments.

Similar content being viewed by others

References

  1. Bettermann, K., Benesch, M., Weis, S. & Haybaeck, J. SUMOylation in carcinogenesis. Cancer Lett. 316, 113–125 (2012).

    Article  CAS  Google Scholar 

  2. Dou, H., Huang, C., Van Nguyen, T., Lu, L.S. & Yeh, E.T. SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett. 585, 2891–2896 (2011).

    Article  CAS  Google Scholar 

  3. Meulmeester, E. & Melchior, F. Cell biology: SUMO. Nature 452, 709–711 (2008).

    Article  CAS  Google Scholar 

  4. Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252–6258 (2000).

    Article  CAS  Google Scholar 

  5. Tatham, M.H., Matic, I., Mann, M. & Hay, R.T. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci. Signal. 4, rs4 (2011).

    Article  CAS  Google Scholar 

  6. Rodriguez, M.S., Dargemont, C. & Hay, R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654–12659 (2001).

    Article  CAS  Google Scholar 

  7. Hay, R.T. SUMO: a history of modification. Mol. Cell 18, 1–12 (2005).

    Article  CAS  Google Scholar 

  8. Tatham, M.H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368–35374 (2001).

    Article  CAS  Google Scholar 

  9. Matic, I. et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high-accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell. Proteomics 7, 132–144 (2008).

    Article  CAS  Google Scholar 

  10. Galisson, F. et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol. Cell. Proteomics 10, M110.004796 (2011).

    Article  Google Scholar 

  11. Geiss-Friedlander, R. & Melchior, F. Concepts in SUMOylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947–956 (2007).

    Article  CAS  Google Scholar 

  12. Gareau, J.R. & Lima, C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861–871 (2010).

    Article  CAS  Google Scholar 

  13. Sampson, D.A., Wang, M. & Matunis, M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276, 21664–21669 (2001).

    Article  CAS  Google Scholar 

  14. Duan, X., Trent, J.O. & Ye, H. Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug design. Anticancer Agents Med. Chem. 9, 51–54 (2009).

    Article  CAS  Google Scholar 

  15. Hershko, A., Ciechanover, A. & Varshavsky, A. Basic Medical Research Award. The ubiquitin system. Nat. Med. 6, 1073–1081 (2000).

    Article  CAS  Google Scholar 

  16. Lamoliatte, F. et al. Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling. Nat. Commun. 5, 5409 (2014).

    Article  CAS  Google Scholar 

  17. Flotho, A. et al. Recombinant reconstitution of SUMOylation reactions in vitro. Methods Mol. Biol. 832, 93–110 (2012).

    Article  CAS  Google Scholar 

  18. Weber, A.R., Schuermann, D. & Schar, P. Versatile recombinant SUMOylation system for the production of SUMO-modified protein. PLoS ONE 9, e102157 (2014).

    Article  Google Scholar 

  19. Werner, A., Moutty, M.C., Moller, U. & Melchior, F. Performing in vitro SUMOylation reactions using recombinant enzymes. Methods Mol. Biol. 497, 187–199 (2009).

    Article  CAS  Google Scholar 

  20. Knipscheer, P. et al. Ubc9 SUMOylation regulates SUMO target discrimination. Mol. Cell 31, 371–382 (2008).

    Article  CAS  Google Scholar 

  21. Sarge, K.D. & Park-Sarge, O.K. Detection of proteins sumoylated in vivo and in vitro. Methods Mol. Biol. 590, 265–277 (2009).

    Article  CAS  Google Scholar 

  22. Hendriks, I.A. et al. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 21, 927–936 (2014).

    Article  CAS  Google Scholar 

  23. Impens, F., Radoshevich, L., Cossart, P. & Ribet, D. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli. Proc. Natl. Acad. Sci. USA 111, 12432–12437 (2014).

    Article  CAS  Google Scholar 

  24. Tammsalu, T. et al. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 7, rs2 (2014).

    Article  Google Scholar 

  25. Barysch, S.V., Dittner, C., Flotho, A., Becker, J. & Melchior, F. Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies. Nat. Protoc. 9, 896–909 (2014).

    Article  CAS  Google Scholar 

  26. Becker, J. et al. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 20, 525–531 (2013).

    Article  CAS  Google Scholar 

  27. Hsiao, H.H., Meulmeester, E., Frank, B.T., Melchior, F. & Urlaub, H. 'ChopNSpice,' a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides. Mol. Cell. Proteomics 8, 2664–2675 (2009).

    Article  CAS  Google Scholar 

  28. Pedrioli, P.G. et al. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3, 533–539 (2006).

    Article  CAS  Google Scholar 

  29. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794–1805 (2011).

    Article  CAS  Google Scholar 

  30. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).

    Article  CAS  Google Scholar 

  31. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513–2526 (2014).

    Article  CAS  Google Scholar 

  32. Lamoliatte, F. et al. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions. Mol. Cell. Proteomics 12, 2536–2550 (2013).

    Article  CAS  Google Scholar 

  33. Wisniewski, J.R., Hein, M.Y., Cox, J. & Mann, M. A 'Proteomic Ruler' for protein copy number and concentration estimation without spike-in standards. Mol. Cell. Proteomics 13, 3497–3506 (2014).

    Article  CAS  Google Scholar 

  34. Beck, M. et al. The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549 (2011).

    Article  Google Scholar 

Download references

Acknowledgements

This work was funded by the Natural Sciences and Engineering Research Council (NSERC) and Genome Canada. F.P.M. is the recipient of postdoctoral fellowship from NSERC. We thank F. Lamoliatte for technical assistance with the MS analysis, and A. Verreault for PCNA and CBX1 recombinant proteins and for the plasmid encoding CHAF1A. The Institute for Research in Immunology and Cancer (IRIC, Université de Montréal, Montréal, Québec, Canada) receives infrastructure support from IRICoR, the Canadian Foundation for Innovation and the Fonds de Recherche du Québec–Santé (FRQS).

Author information

Authors and Affiliations

Authors

Contributions

F.P.M. and C.D.A. carried out molecular biology and blotting experiments with the SUMO3 variant. F.P.M. prepared and optimized the current protocol and performed the LC-MS/MS experiments and analyzed the data. F.P.M. and P.T. wrote the manuscript. P.T. developed the concept and managed the project.

Corresponding author

Correspondence to Pierre Thibault.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Comparison of in vitro SUMOylation assay for RanGAP using native SUMO3 and SUMO3 (NQTGG) mutant.

(a) Western blot showing the SUMOylation of RanGAP with native and mutant SUMO3 proteins with and without ATP. MS/MS spectra of the Lys-524 SUMOylated RanGAP peptide with (b) SUMO3 (NQTGG) mutant and (c) native SUMO3 proteins. A series of b- and y-type fragment ions corresponding to the tryptic peptide with a modified K-198 residue is observed when using the SUMO3 mutant and facilitated its identification by the search engine Andromeda. In contrast, limited fragmentation of the peptide backbone is noted for the native SUMO3, and the corresponding MS/MS spectrum could not be identified by Andromeda.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1 and Supplementary Table 1 (PDF 475 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McManus, F., Altamirano, C. & Thibault, P. In vitro assay to determine SUMOylation sites on protein substrates. Nat Protoc 11, 387–397 (2016). https://doi.org/10.1038/nprot.2016.023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2016.023

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing